Literature DB >> 23526421

On the role of notch1 and adult hepatocytes in murine intrahepatic cholangiocarcinoma development.

Matthias Evert1, Frank Dombrowski, Biao Fan, Silvia Ribback, Xin Chen, Diego F Calvisi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23526421     DOI： 10.1002/hep.26411

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  7 in total

1.  Oncogenic potential of IDH1R132C mutant in cholangiocarcinoma development in mice.

Authors:  Ning Ding; Li Che; Xiao-Lei Li; Yan Liu; Li-Jie Jiang; Biao Fan; Jun-Yan Tao; Xin Chen; Jia-Fu Ji
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

Review 2.  Hydrodynamic transfection for generation of novel mouse models for liver cancer research.

Authors:  Xin Chen; Diego F Calvisi
Journal:  Am J Pathol       Date:  2014-01-28       Impact factor: 4.307

3.  Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans.

Authors:  L Che; B Fan; M G Pilo; Z Xu; Y Liu; A Cigliano; A Cossu; G Palmieri; R M Pascale; A Porcu; G Vidili; M Serra; F Dombrowski; S Ribback; D F Calvisi; X Chen
Journal:  Oncogenesis       Date:  2016-12-05       Impact factor: 7.485

4.  NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesis.

Authors:  Sarah Luiken; Angelika Fraas; Matthias Bieg; Raisatun Sugiyanto; Benjamin Goeppert; Stephan Singer; Carolin Ploeger; Gregor Warsow; Jens U Marquardt; Carsten Sticht; Carolina De La Torre; Stefan Pusch; Arianeb Mehrabi; Norbert Gretz; Matthias Schlesner; Roland Eils; Peter Schirmacher; Thomas Longerich; Stephanie Roessler
Journal:  Oncogene       Date:  2020-02-13       Impact factor: 9.867

Review 5.  Recent Advances in Implantation-Based Genetic Modeling of Biliary Carcinogenesis in Mice.

Authors:  Masashi Izumiya; Shingo Kato; Yoshitaka Hippo
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

6.  Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.

Authors:  F Peng; J Jiang; Y Yu; R Tian; X Guo; X Li; M Shen; M Xu; F Zhu; C Shi; J Hu; M Wang; R Qin
Journal:  Br J Cancer       Date:  2013-10-29       Impact factor: 7.640

7.  Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model.

Authors:  Mingjie Dong; Xianqiong Liu; Katja Evert; Kirsten Utpatel; Michele Peters; Shanshan Zhang; Zhong Xu; Li Che; Antonio Cigliano; Silvia Ribback; Frank Dombrowski; Antonio Cossu; John Gordan; Diego F Calvisi; Matthias Evert; Yan Liu; Xin Chen
Journal:  Cell Death Dis       Date:  2018-01-18       Impact factor: 8.469
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.